Drug
Raxibacumab
Raxibacumab: highest development phase Phase 3, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| raxibacumab NCT00639678 | Phase 3 | Healthy |
Latest
No recent events.
Follow Raxibacumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.